Signaling pathways
-
BA2623 VcMMAESummary: VcMMAE (mc-vc-PAB-MMAE) is part of the antibody-coupled active molecule. -
BA2624 CL2A-SN-38Summary: CL2A-SN-38 is, linked by linkerCL2A and toxic molecule SN-38, which can be used to prepare antibody coupled active molecules (ADCs). -
BA2625 Val-Cit-PAB-MMAESummary: Val-Cit-PAB-MMAE is part of the antibody-coupled active molecule. -
BA2626 PC5-VC-PAB-MMAESummary: PC5-VC-PAB-MMAE consists of (PC5-VC-PAB) and MMAE, a potent microtubule inhibitor. -
BA2628 SMCC-DM1Summary: SMCC-DM1 (DM1-SMCC) is formed by linking the linkerSMCC to the toxic molecule DM1 and can be used to prepare antibody-coupled active molecules. -
BA2629 MC-Val-Cit-PAB-MMAFSummary: MC-Val-Cit-PAB-MMAF (Vc-MMAF) is an antibody-coupled compound. -
BA2630 DBCO-PEG4-VC-PAB-MMAESummary: DBCO-PEG4-VC-PAB-MMAE consists of (DBCO-PEG4-VC-PAB) and the microtubule protein polymerization inhibitor MMAE. -
BA2631 Mal-VC-PAB-DM1Summary: Mal-VC-PAB-DM1 is part of an antibody-coupled active molecule. -
BA2632 SPDB-DM4Summary: The SPDB-DM4 is part of the ADC. -
BA2634 Mc-VC-PAB-SN38Summary: Mc-VC-PAB-SN38 consists of degradable (cleavable) (Mc-VC-PAB) and SN38, a DNA topoisomerase I inhibitor.

